Active Risk Identification and Analysis (ARIA)

Active Risk Identification and Analysis (ARIA) is FDA’s active post-market risk identification and analysis system, which is comprised of pre-defined, parameterized, re-usable routine querying tools that enable safety surveillance in Sentinel. In contrast to a traditional pharmacoepidemiology study, there is no protocol and no customized programming. ARIA fulfills the FDA’s Amendments Act mandate to conduct drug/medical product safety surveillance.

 

A graphic illustrating the current and future capabilities of Active Risk Identification and Analysis  (ARIA) with respect to fulfilling level 1 queries, level 2 queries, level 3 queries.

For technical details concerning all of Sentinel’s analytic tools that support ARIA, click here.